Appropriate Use Criteria For Amyloid PET
Publication Date: January 1, 2013
Last Updated: March 14, 2022
Appropriate Indications
Patients with persistent or progressive unexplained mild cognitive impairment (MCI)
6731
Not Appropriate Indications
Patients with core clinical criteria for probable AD with typical age of onset
6731
Title
Appropriate Use Criteria For Amyloid PET
Authoring Organizations
Society of Nuclear Medicine and Molecular Imaging